Does Semaglutide Get Rid of Belly Fat — and How Much?

The decision most people are really making

When someone searches whether semaglutide gets rid of belly fat, they are usually weighing up two things at once: does this medicine actually work for abdominal fat specifically, and is it the right move for me personally? Those are different questions, and they deserve separate answers.

On the first: yes, people who lose significant body weight on semaglutide do typically see reductions in waist circumference. On the second: that depends on your health history, your BMI, any existing conditions, and a clinical conversation. The rest of this page covers what the science says and what to realistically expect, so you can arrive at that conversation well-informed.

A practical check you can do right now, measure your waist at the level of your belly button, relaxed and not sucked in. For most adults, a measurement above 88 cm (women) or 102 cm (men) is classed as high risk by NHS healthy weight guidance. Knowing your number gives a prescriber useful context and gives you a baseline to track against.

How semaglutide affects abdominal fat, specifically

Semaglutide acts on GLP-1 receptors in the brain and gut, blunting hunger signals and slowing how quickly food leaves the stomach. The result is that people eat less, consistently, over weeks and months. That sustained calorie deficit is what drives weight loss, semaglutide does not dissolve fat directly or target any particular region of the body.

So why does belly fat feature so prominently in the results? Visceral fat (the kind that accumulates around the liver, pancreas and intestines) is metabolically active. It responds to an energy deficit more readily than subcutaneous fat elsewhere, which is one reason waist measurements often fall faster than, say, hip measurements. In the STEP 1 trial, published in the New England Journal of Medicine, participants on semaglutide 2.4 mg lost an average of around 15% of body weight over 68 weeks alongside lifestyle changes. Reductions in waist circumference were recorded as a secondary outcome and were clinically meaningful across the group.

For more on the specific mechanisms and what the trial data covers, this page on semaglutide and belly fat goes into greater depth on the biology.

What semaglutide cannot do, and what that means for expectations

Where your body loses fat first, and in what proportions, is largely dictated by genetics and hormone profile. Semaglutide influences the amount of fat your body loses; it cannot dictate the location. Some people will notice their trousers loosening early; others will lose weight more evenly across the body before the abdomen shifts. Both are normal. If you want to understand whether Wegovy specifically helps with losing belly fat, the picture is that average results across populations can look compelling while individual responses vary quite a bit.

It is also worth being clear about what semaglutide is and is not approved for. Wegovy (the semaglutide brand licensed for weight management in the UK) is indicated for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition. NICE's appraisal of semaglutide (TA875) sets out the clinical framework that NHS services follow. Private prescribing follows the same licensed eligibility criteria, with a prescriber making the final call on suitability.

Semaglutide is not appropriate during pregnancy, while breastfeeding, or for anyone trying to conceive. It is not licensed for use under 18. Anyone with a history of pancreatitis or certain other conditions will need to discuss this carefully with a prescriber before starting.

For a balanced picture of what to expect on treatment, our overview of semaglutide's side effects is a useful read alongside this one. Gastrointestinal symptoms (nausea, loose stools, indigestion) are the most commonly reported, usually most noticeable in the first weeks and settling as the body adjusts.

If this is the route you want to explore

The honest picture is this: semaglutide, used alongside dietary changes and activity, produces meaningful weight loss for many people, and abdominal fat tends to reduce as part of that. It is not a targeted belly-fat treatment, and it is not right for everyone. But for people who meet the clinical criteria, the evidence is substantial.

Our weight-loss treatment overview covers the options available through nume (Wegovy injection, the newer oral Wegovy tablet, and Mounjaro) with a plain summary of how they compare. Thinking about cost? The Wegovy pricing page explains what is included in a private prescription and what the market looks like at the moment.

If you are ready to find out whether semaglutide is clinically suitable for you, start your free consultation with our prescribers. A real clinician reads every submission the same day, not automated software. Treatment is dispatched the same day if approved, delivered free the next working day.